Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+19.5%
5Y CAGR+19.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+19.5%/yr
vs +9.0%/yr prior
5Y CAGR
+19.4%/yr
Consistent
Acceleration
+10.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.66B | +5.1% |
| 2024 | $8.24B | +26.3% |
| 2023 | $6.52B | +28.4% |
| 2022 | $5.08B | +15.5% |
| 2021 | $4.40B | +23.5% |
| 2020 | $3.56B | +5.7% |
| 2019 | $3.37B | -6.2% |
| 2018 | $3.59B | +10.6% |
| 2017 | $3.25B | +4.0% |
| 2016 | $3.13B | - |